NCT02342951View on ClinicalTrials.gov

Evaluation of the Lung Clearance Index

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2019

Study Completion Date

July 31, 2019

Conditions
Cystic Fibrosis
Interventions
OTHER

Lung clearance index determination

Lung clearance index determination

Trial Locations (1)

75015

Hôpital Necker-Enfants Malades, Paris

All Listed Sponsors
collaborator

Vaincre la Mucoviscidose

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02342951 - Evaluation of the Lung Clearance Index | Biotech Hunter | Biotech Hunter